Ann: ResApp Provides Updated Australian Paediatric Study Results, page-57

A point to consider is, what accuracy level do we require for a commercial viable business?

-Doctors are buying stethoscopes to get ~ 50-60% accuracy.
-Hospitals spends $10,000’s on x-rays to get ~ 70% accuracy
-Patients pay doctors $100’s and wait days to get x-ray/sputum/blood results

Why wouldn’t you pay $5-$10 for an instant diagnosis from the conveniences of your own bed via telehealth to get over 90% accuracy for most respiratory diseases?

RAP have; over 90% accuracy for most respiratory related illnesses, and is faster, more convenient & cheaper than alternatives. In most cases, this will provide a more suitable option for patients than current diagnostic tools available which makes the business not only viable but very profitable given the large market size & scalability.

Also, its worth noting the FDA approval isn’t on accuracy alone. The above mentioned diagnostic alternatives are in practise at those low accuracy rates hence i think FDA is a given.